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How do killer cells restrain perforin, the most potent toxin known to biologists, at its point of synthesis in the
endoplasmic reticulum, where conditions are ideal for its activation? In this issue of Immunity, Brennan et al.
(2011) study its trafficking, offering insights into protective mechanisms.Perforin (PFN) is a 67-kilodalton multido-
main protein that consists of an amino-
terminal membrane attack complex
perforin-like-cholesterol dependent cyto-
lysin (MACPF - CDC) domain (Rosado
et al., 2007), followed by an epidermal
growth factor (EGF) domain and ending
with a carboxy-terminal sequence within
which a C2 domain mediates Ca2+-
dependent membrane binding. Quite
recently, the structural identity of perforin
pores formed in liposomal membranes
was determined through a remarkable
collaborative effort of cellular and
structural biologists (Law et al., 2010).
Members of this community now have
examined how this potent toxin might be
contained after its synthesis in killer cells.
The Griffiths lab was the first to
illuminate mechanism(s) underlying the
synthesis, processing and intracellular
transport of perforin in a NK cell line. Their
efforts indicated that PFN is synthesized
as an inactive precursor, which is cleaved
in cytotoxic granules apparently at the
C terminus to yield an active monomer
(Uellner et al., 1997). They proposed that
removal of the C terminus encourages
the interaction of Ca2+ ions with binding
sites within the C2 domain, which then
allows contact with the lipid bilayer
and monomer oligomerization. However,
recent structural data indicate the
C terminus does not lie in apposition to
the Ca2+ binding sites (Law et al.2010),
suggesting that it might serve other func-
tions and that protection of the host cell
utilizes a different mechanism.
In this issue of Immunity, Brennan et al.
(2011) examined the importance of the
last 12 C-terminal amino acids and
terminal glycosylation site in intracellular
transport. They observed perforin auto-
toxicity with mutations that delayed itstransport out of the endoplasmic retic-
ulum (ER), thus providing an alternate
protective mechanism that might be
attributable to its rapid egress from the
ER, a remarkable feat indeed for a labile
protein with 10 disulfide bonds and two
N glycosylation sites (Brennan et al.,
2011). In addition, they offer evidence for
the first time that the precursor monomer
is dormant and that C-terminal process-
ing of perforin may not be required for
activation of perforin as previously
suspected.
The investigators first examined
whether the final 12 amino acid span influ-
enced the permeabilizing activity of the
monomer. Here, a mutant was created in
which a protease cleavage site was in-
serted 12 amino acids from the carboxy
terminus. Unexpectedly, when expressed
in baculovirus, the isolated insect
‘‘zymogen’’ and the cleaved monomer
manifested equivalent membranolytic
activity against sheep erythrocytes and
possessed an equal capacity to deliver
granzyme B (GzmB) into target cells. This
observation supports data indicating
that, after Ag-specific activation, virus-
specific CD8+ T cells rapidly synthesize
perforin in a form that does not pass
through the cytotoxic granule and thus
would represent the unprocessedMACPF
protein, namely PFN with an intact C
terminus (Makedonas et al., 2009).
PFN activity also did not depend what-
soever on the glycosylation state of the
monomer inasmuch as the enzymatically
deglycosylated wild-type PFN or a
construct that lacked the two known
glycosylation sites were quite cytotoxic.
On the basis of these data, the investiga-
tors considered the possibility that the
extreme C-terminal peptide and the
attached glycans are essential for accu-Immunityrate vesicular trafficking from the endo-
plasmic reticulum through the vesicular
tubular clusters and Golgi stacks onward
to the secretory lysosomes, a pathway
followed bymany glycoproteins (Hughson
and Reinisch, 2010).
As a first step in evaluating the engi-
neered PFN mutants, their endogenous
cytotoxicity was evaluated after transient
expression. The PFN mutants that lacked
the last 12 AA (DEL-12) or the glycosyla-
tion site (Gly2) were found to be toxic
when expressed in either rat basophilic
leukemia (RBL) cells, primary murine
cytotoxic T lymphocytes (CTLs), or a
human natural killer (NK) cell line in which
endogenous PFN expression was sup-
pressed. Here, cell death was monitored
as a reduction in a coexpressed green
fluorescent protein (GFP) signal. The
rather small differences in the GFP levels
between the WT and mutants would
suggest that an alternate readout might
have been helpful to assess the data. In
some experiments, cell death induced
by the mutants was monitored with
propidium iodide, but even here only
15%–20% cells were killed implying
that GFP and mutant expression might
not have been as tightly linked as antici-
pated. Nevertheless, this concern was
overcome quite elegantly through a
rescue approach by engineering addi-
tional substitutions that would abrogate
calcium dependent membrane binding
of the expressed mutants (Voskoboinik
et al., 2005). Finally, the final C-terminal
residue (W555) was found to be most
crucial in protecting the cells against
PFN toxicity presumably by facilitating
trafficking (Figure 1).
On the basis of these data, the hypoth-
esis was presented that the C terminus of
PFN might be required for exit of the34, June 24, 2011 ª2011 Elsevier Inc. 823
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Figure 1. C-Terminal and Glycosylation Mutants of Perforin and Their Trafficking
to Cytotoxic Granules during Transient Expression in RBLs, Primary CTLs and a Human
NK Cell Line
A schematic of the different mutants used by Brennan et al. (2011). On the left, diamonds represent
N-linked glycosylation sites and the Xs define mutants in which site is deleted. The panel indicates traf-
ficking from the endoplasmic reticulum (ER) through the vesicular-tubular clusters (VTCs) to the trans-
Golgi network (TGN). The red line indicates the pattern of trafficking of the various mutants. Broken lines
describe a delayed transition compared to WT PFN. The leftward panel indicates whether a particular
mutant was associated with increased cell death during transient expression.
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Previewssynthesized monomers from the ER,
that is, essential for proper folding. In
addressing this question, the intracellular
localization of relevant mutants was
examined: DEL-12 and Gly2 and another
in which the terminal hydrophobic AA
was replaced with a serine (WS). Due to
the limitations of the transient expression
system, a sufficient number of cells would
not be available to perform traditional
buoyant density centrifugation. As an
alternative, trafficking was observed by
performing confocal laser scanning
microscopy (CLSM) at 37C with a PFN
mAb and relevant compartment specific
mAbs plus the developing secondary
reagents. At steady state, the majority of
WT PFN colocalized with lysosomal asso-
ciated membrane protein-1 (LAMP-1)
indicating that the monomer, as ex-
pected, is sorted into the lysosomal and/
or granule compartment. However, when
the intensity of the laser was increased,
the various C-terminal mutants were
found to be associated with the granule
compartment to some degree. This was824 Immunity 34, June 24, 2011 ª2011 Elsevan unexpected observation, given that
these PFN mutants were toxic but ap-
peared nonetheless to have undergone
partial trafficking from the ER to the secre-
tory granules. Alternatively, these mis-
folded mutants may have trafficked
instead to (LAMP-1) positive degradative
structures (e.g., autophagosomes).
To reconcile these findings, the possi-
bility was considered that mutant PFNs
could have a delayed rate of export from
the ER and that toxicity may be most
pronounced in this compartment. To
compare the rates of WT and mutant
PFN trafficking, cells expressing the
mutants were incubated at reduced
temperature that would impair egress
from the ER, which was followed by an
increase to 37C to enhance their mobili-
zation. Colocalization of the mutant of
interest within the ER and trans-Goligi
network (TGN) was then determined as
described above. Here, WT PFN was ex-
ported from the ER within 30 min after
the temperature was increased whereas
the WS and Del-12 mutants were incom-ier Inc.pletely retained when examined at 2 hr.
The subcellular localization of a mutant
lacking the 19 C-terminal amino acids
(Del-19) also was examined. In contrast
to the Del-12 and WS mutants, Del-19
was retained completely but at the same
time lacked cytotoxic activity (Figure 1).
Offering further support for their obser-
vation that a delayed exist of PFN from the
ER was highly detrimental, the wild-type
monomer was expressed at reduced
temperature in the presence of Brefeldin
A, a potent microtubule inhibitor that
disrupt ER to Golgi transport. Under these
conditions, which markedly enforce
retention of the WT monomer in the ER,
cell death was substantial. As a further
examination of the idea that PFN kills if
the monomer does not promptly exit the
ER, a canonical ER retention motif was
added downstream of the C terminus of
the WT monomer. After transient trans-
fection in RBL cells under steady state
conditions, this mutant displayed the
anticipated toxic phenotype. Overall, the
data indicate that the C terminus, espe-
cially the last residue, regulates PFN
export from the ER and if the active PFN
is retained in this compartment, the cell
will likely die (Figure 1).
Similar methods were then used to
determine whether the glycosylation state
of the monomer contributed to delivery of
PFN to the secretory lysosomes. A doubly
unglycosylated mutant was produced
and expressed in the RBL cells. Interest-
ingly, this double mutant failed to kill the
RBL cells whereas stripping the sugars
from the WT PFN left the permeabilizing
activity of the monomer undiminished
when the isolated protein was added to
target cells. Together, the results indicate
that the glycosylation state is not crucial
for lytic activity but, instead, may be
necessary for trafficking to the secretory
granules. Furthermore, if the monomer is
not properly glycosylated, the misfolded
protein is diverted to a degradation
pathway limiting its toxicity, a concept
supported by the lower levels of Gly1,
Gly2, and Gly1+Gly2 mutants expressed
in RBL cells.
These remarkable studies establish
that pro-PFN as expressed in baculovirus
is as active as the mature form and lends
support to the observation that PFN may
be secreted constitutively under certain
conditions in vivo (Makedonas et al.,
2009; Urrea Moreno et al., 2009). Instead,
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Previewsthe C terminus appears to regulate traf-
ficking of this highly toxic protein.
Perhaps the most compelling questions
remain, however. What mechanisms
restrain this toxic protein as it traverses
organelles so rich in phospholipids that
would support its binding and oligomeri-
zation? Are there specific chaperones
unique to PFN that hasten the monomer
through the ER and TGN? Is the phospho-
lipid composition of the organelles
less desirable than the content of the
external leaflet of the plasma membrane
dissuading the monomer from enforcing
its destructive tendencies (Yang et al.,
2010)? And, would the protective mecha-
nisms differ for PFN that is subjected to
regulated versus constitutive secretion?
Although these questions loom large, itwould at least appear that the endo-
plasmic reticulum regards nascently
synthesized perforin as an unwelcome
occupant and is prepared to evict this
tenant posthaste.
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Movement of immunoreceptor microclusters tunes lymphocyte activation, but the underlying mechanisms
are incompletely understood. In this issue of Immunity, Schnyder et al. (2011) and Hashimoto-Tane et al.
(2011) show that cytoplasmic dynein drives microcluster centralization along microtubules.Lymphocyte activation involves a high
degree of spatiotemporal control. Initial
T cell receptor (TCR) signaling drives re-
modeling of cytoskeletal elements at the
Tcell–antigen-presenting cell contact site,
forming the scaffold for the ‘‘immunolog-
ical synapse’’ (IS) (Burkhardt et al., 2008).
This polarized cortical domain sustains
cell-cell adhesion and promotes subse-
quent signaling events needed for full
T cell activation. Recently, it has become
clear that B cell recognition of surface-
bound antigens involves a similar cyto-
architecture, which in this case serves to
facilitate B cell receptor (BCR) signaling
and antigen internalization (Harwood and
Batista, 2010).
As early as the 1980s, several groups
studying the T cell response observed
polarization of the actin cytoskeleton aswell as the microtubule-organizing center
(MTOC) and associated secretory organ-
elles toward the T cell–antigen-presenting
cell binding site (Kupfer and Singer, 1989).
Initially, the field focused on the role of
cytoskeletal elements in promoting polar-
ized effector function. In particular, it was
noted that lytic granules and cytokine-
containing secretory vesicles associate
with the MTOC, such that polarization of
the microtubule array sets the stage for
delivery of cytotoxins or cytokines to the
intended target cell. Recent research in
this arena has focused on defining the
signaling events that control the polariza-
tion of the MTOC and associated secre-
tory organelles (Huse et al., 2008; Lasserre
and Alcover, 2010). Available evidence
points to a tension-based mechanism
driven by the minus-end-directed micro-tubule motor protein cytoplasmic dynein,
anchored to the T cell cortex at sites of
T cell signaling. Numerous other proteins
have also been implicated in MTOC reor-
ientation, including LFA-1 and the adaptor
protein ADAP, the formins diaphanous
and FLH1, the actin-binding protein
ezrin and associated PDZ-domain protein
hDLG1, diacylglycerol and PKC, and the
tubulin regulatory histone deacetylase
HDAC6. The mechanisms through which
these diverse molecules coordinate
MTOC reorientation remain to be
elucidated.
In addition to organizing effector func-
tion, the T cell cytoskeleton serves as
a dynamic scaffold for TCR signaling.
Actin polymerization is needed to initiate
and sustain TCR signals, and high-resolu-
tion imaging techniques show that actin34, June 24, 2011 ª2011 Elsevier Inc. 825
